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Abstract: Human exposure to environmental contami-
nants such as persistent chlorinated organics, heavy met-
als, pesticides, phthalates, flame retardants, electronic 
waste and airborne pollutants around the world, and 
especially in Southeast Asian regions, are significant and 
require urgent attention. Given this widespread contami-
nation and abundance of such toxins as persistent organic 
pollutants (POPs) in the ecosystem, it is unlikely that 
remediation alone will be sufficient to address the health 
impacts associated with this exposure. Furthermore, we 
must assume that the impact on health of some of these 
contaminants results in populations with extraordinary 
vulnerabilities to disease risks. Further exacerbating risk; 
infectious diseases, poverty and malnutrition are com-
mon in the Southeast Asian regions of the world. Thus, 
exploring preventive measures of environmental expo-
sure and disease risk through new paradigms of environ-
mental toxicology, optimal and/or healthful nutrition and 
health is essential. For example, folic acid supplemen-
tation can lower blood arsenic levels, and plant-derived 
bioactive nutrients can lower cardiovascular and cancer 
risks linked to pollutant exposure. Data also indicate that 
diets enriched with bioactive food components such as 
polyphenols and omega-3 polyunsaturated fatty acids can 
prevent or decrease toxicant-induced inflammation. Thus, 
consuming healthy diets that exhibit high levels of anti-
oxidant and anti-inflammatory properties, is a meaning-
ful way to reduce the vulnerability to non-communicable 
diseases linked to environmental toxic insults. This nutri-
tional paradigm in environmental toxicology requires fur-
ther study in order to improve our understanding of the 
relationship between nutrition or other lifestyle modifi-
cations and toxicant-induced diseases. Understanding 
mechanistic relationships between nutritional modula-
tion of environmental toxicants and susceptibility to dis-
ease development are important for both cumulative risk 
assessment and the design and implementation of future 
public health programs and behavioral interventions.
Keywords: bioactive foods; environmental pollutants; 
inflammatory diseases.
Introduction
The pathologies of non-communicable, chronic diseases 
such as atherosclerosis, diabetes, obesity and nonalcoholic 
liver disease are complex and may be influenced by exposure 
to environmental pollutants throughout the lifespan. Their 
etiologies are complex and depend on a dynamic interaction 
between genetics, nutrition, toxicant exposures and the envi-
ronments where we live. Thus, it is vital that public health 
professionals working with at-risk populations not only help 
monitor the ongoing health of exposed communities but also 
promote healthy practices and behaviors in order to prevent 
or reduce the potential for disease pathology.
Such at-risk populations can be found in Southeast 
Asia, which has endured serious environmental health 
challenges that have emerged primarily from decades of 
widespread environmental contamination in the entire 
region, coupled with severe environmental ignorance. 
Past contaminations resulted from the use of defoliants, 
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such as Agent Orange in the Vietnam War, which contrib-
uted to great hardship, such as birth defects (1), cancers (2) 
and skin diseases (3). Other examples include past forest 
fires in Southeast Asia, as well as continued slash-and-
burn techniques adopted by farmers in Indonesia, which 
have been extensively used for many years as the cheap-
est and easiest means to clear the lands for traditional 
agriculture. In addition to persistent organic pollutants 
(POPs), heavy metals and a continued increase in con-
taminated groundwater and indoor/outdoor air pollution, 
emerging hazardous wastes, such as electronic waste, 
have become a major environmental burden for East and 
Southeast Asia. In addition to the challenges of dealing 
with environmental pollution, global warming, etc., there 
is a high incidence of poverty (4, 5), viral infection (6–8) 
and malnutrition (9, 10) in this region of the world.
The 8th Princess Chulabhorn International Science 
Congress, which was held in Bangkok, Thailand in 2016, 
provided opportunities to develop collaborations that 
combine population health discoveries generated in South-
east Asian countries with bench research conducted in 
other parts of the world to advance our overall understand-
ing of environmental health and prevention paradigms. 
Discussions at this international congress included inter-
vention and/or prevention paradigms against environmen-
tal insults and subsequent disease risks. Inspired by these 
discussions, this review summarizes nutritional interven-
tion and/or prevention paradigms to successfully combat 
mechanisms involved in diseases linked to deleterious 
environmental exposures. A particular focus is on POPs, 
including dioxin-like chemicals such as polychlorinated 
biphenyls (PCBs), which, due to their chemical nature and 
persistence in the environment, can generate both short- 
and long-term health challenges for affected community 
members. This mini-review will discuss examples by which 
diet-derived bioactive food components can reduce the risk 
of pathologies of non-communicable diseases, followed by 
evidence that such protective nutrients or bioactive food 
components can modulate or reduce the disease risks asso-
ciated with exposure to environmental pollutants.
Preventative measures of 
 diet-derived bioactive food 
 components against non- 
communicable diseases
Specific foods or natural components within our daily 
diets can modulate environmental insults and thus the 
pathologies of non-communicable diseases. The scien-
tific evidence to support the concept of health promoting 
foods, also referred to as “functional foods”, is growing 
rapidly. Functional foods and herbal supplements contain 
different types of valuable therapeutic agents. Therefore, 
the intensive qualitative and quantitative testing of these 
active ingredients in these products is necessary for their 
effective utilization and reduction of side effects. In Thai-
land and other parts of Southeast Asia, people have used 
herbal products for the treatment of diseases and health 
promotion for a long time. The following are examples of 
functional foods or plant-derived bioactive food compo-
nents used as a means of prevention/intervention against 
non-communicable diseases.
Sesame and cancer
Sesame (Sesamum indicum Linn.) has long been used 
extensively as a traditional food in Eastern countries. 
Sesame seed and oil are widely used in cooking and as 
ingredients of confectionery foods. Sesame seeds contain 
a group of bioactive compounds such as lignans. Sesamin, 
sesamol and sesamolin, which are major lignans in 
sesame seed (11), have many pharmacological proper-
ties, including antioxidant and anti-proliferative activi-
ties, enhancing the antioxidant activity of vitamin E in 
the lipid peroxidation system, lowering cholesterol levels, 
increasing hepatic fatty acid oxidation enzymes, hypoten-
sive effects and neuroprotective effects against hypoxia 
or brain damage (12). In addition, sesame possesses anti-
cancer properties, which appear to be due mainly to its 
anti-proliferative, pro-apoptotic, anti-inflammatory and 
anti-metastatic activities (13). For example, sesamin, a 
major constituent of sesame, can downregulate the secre-
tion of cytokines and the expression of cell proliferative- 
and invasive-related gene products in prostate cancer cells 
(14). Furthermore, sesame lignans and their metabolites 
(e.g. enterodiol, enterolactone) have been shown to have 
estrogenic activities in breast cancer T47D cells (15). In 
addition, frequent consumption of sesame oil was linked 
to lower risk of stomach cancer in humans (16).
Sesame and cardiovascular diseases
Air pollution exposure has been linked to cardiovascular 
disease, with inflammation involved as a suspected mech-
anism (17). A previous study showed that treatment with an 
aqueous extract from sesame seeds significantly reversed 
the changes in all biochemical parameters (notably, lipid 
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peroxidation and aspartate aminotransferase) evaluated 
in serum and heart homogenates of cadmium-induced car-
diotoxicity in rats (18). In that study, exposure to cadmium 
in drinking water caused pronounced oxidative stress and 
cardiac tissue damage in rats, and an aqueous extract of 
sesame seeds possessed antioxidant and cardioprotec-
tive effects in a dose-dependent manner without the signs 
of toxicity. Results from a study of dietary black sesame 
meal on blood pressure and oxidative stress in patients 
with prehypertension showed that a 4-week administra-
tion of black sesame meal significantly decreased systolic 
blood pressure and plasma malondialdehyde levels, and 
increased vitamin E levels (19). It is likely that the anti-
hypertensive effect of this black sesame meal is due to 
decreased oxidative stress and improving antioxidant 
status in the body (vitamin E levels). In another study 
with 38  hyperlipidemic patients in Iran, consuming 40 
g of white sesame seeds daily for 60  days was linked to 
significant decreases in levels of serum total cholesterol 
(TC), low-density lipoprotein cholesterol (LDL-C) and 
TC/HDL-C ratio (20). However, serum triglyceride (TG) 
and high-density lipoprotein (HDL-C) concentrations 
remained unchanged during the study. It is possible that 
these lipid changes are related in part to bile acid metabo-
lism, because associations between body fat content, HDL 
and triglycerides and some secondary bile acid plasma 
concentrations were found in healthy adults (21).
Longan fruit
Fruit and vegetables contain many antioxidant com-
pounds, including carotenoids, thiols, glucosinolates, fla-
vonoids and phenolics. An increase in the consumption of 
antioxidants from these foods can reduce oxidative stress 
and prevent chronic diseases, including those linked to 
pollution exposure and associated inflammation. Longan 
fruit (Dimocarpus longan Lour.) is a subtropical fruit, 
known as “Lumyai” in Thailand. It is widely grown in 
China, Taiwan and Southeast Asia including Thailand 
and Vietnam and is consumed in both fresh and processed 
products such as canned longan in syrup or dried fruit, as 
well as fruit drinks. Longan extracts contain high levels 
of polyphenolic compounds such as corilagin, gallic acid 
and ellagic acid (22). Dried seed was found to contain the 
highest levels of these three compounds while dried pulp 
contained the lowest. Water extracts of longan seed and 
pulp contained high levels of gallic acid and ellagic acid 
and exhibited the highest radical scavenging activities 
(23). These data suggest that longan seed extract could be 
another potential source of natural dietary antioxidants. 
In addition, extracts from the longan fruit exhibited anti-
inflammatory properties. Mechanisms underlying these 
effects were related to nitric oxide (NO) scavenging and 
inhibition of inducible nitric oxide synthase (iNOS) (24). 
Therefore, longan extracts may be potential natural ingre-
dients for the treatment of inflammatory-related diseases.
Chemoprevention by xanthohumol
Exposure to persistent organic chemicals has been linked 
to cancer (25). One possibility of cancer prevention may 
involve the use of chemicals or dietary components to 
block, inhibit or reverse the development of cancer in 
normal or preneoplastic tissues. Prenylated chalcones 
and flavonoids may be important in cancer prevention. 
These naturally occurring compounds, which include 
xanthohumol, exhibit antioxidant and anti-inflammatory 
properties, and can modulate the metabolism of carcino-
gens by inhibition of distinct phase 1 metabolic enzymes 
and activation of phase 2 detoxifying enzymes (26). In a 
recent human study it was found that xanthohumol can 
prevent DNA damage by dietary carcinogens, such as 
2-amino-3-methylimidazo[4,5-f]quinolone (27), which 
can be formed during the cooking of meat and fish (28). 
Also, xanthohumol can have anti-inflammatory actions in 
cancer cells by suppressing prostaglandin E2 production 
and cell migration (29). Furthermore, xanthohumol can 
prevent carbon tetrachloride-induced acute liver injury 
due to its antioxidant properties (30).
Xanthohumol is a prenylated flavonoid found in hops, 
which is used in the beer brewing process contributing to 
the bitterness and the aroma of beer. In addition, many 
non-alcoholic drinks and foods are rich in xanthohumol, 
which has implications in human intervention trials. For 
example, xanthohumol enriched soft drinks and teas are 
commercially available, as well as muesli bars, chocolate, 
yogurt and biscuits. A human study was planned in which 
volunteers consumed nonalcoholic beverages containing 
xanthohumol or placebo drinks for 2  weeks (31). Altera-
tions of DNA stability was monitored in lymphocytes and 
a decrease of oxidatively damaged purines was found (31). 
In addition, a lower formation of reactive oxygen species 
was observed as monitored by a reduced excretion of 
8-oxo-guanosine in urine. Other biochemical parameters 
reflecting the redox and hormonal status and lipid and 
glucose metabolism were not altered after the interven-
tion. These data suggest that xanthohumol is a cancer 
chemopreventive agent in animal studies, and it also can 
exhibit DNA protecting properties in humans.
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Chemoprevention of aerodigestive 
tract cancers by berries
Epidemiological investigations support the notion that 
increased consumption of diets rich in fruit, vegetables, 
antioxidants and fiber reduces the risk for cancers of the 
aerodigestive tract. The inverse association between plant-
based diets and cancer has led to evaluations of food-based 
constituents in a variety of preclinical models to decipher 
cancer inhibitory mechanisms and potential targets (32–
35). Promising results have supported early phase clinical 
trials in cohorts at increased risk for cancer progression due 
to existing premalignancy or genetic alterations (36–39). 
Positive effects of cranberries or cranberry-derived con-
stituents have been reported against 16 different cancers 
(45 cancer cell lines) utilizing a variety of in vitro methods 
[reviewed in (35)]. Furthermore, in vivo studies support 
the inhibitory action of cranberries toward cancers of the 
esophagus, stomach, colon, bladder,  prostate, glioblas-
toma and lymphoma (35). To date, reported mechanisms of 
cranberry-linked cancer inhibition include cellular death 
induction via apoptosis, necrosis and autophagy; inhibi-
tion of cellular proliferation and modulation of cell cycle 
kinetics; alterations in reactive oxygen species; as well as 
modification of cytokine and signal transduction path-
ways (32–35, 40). Additional proposed mechanisms are 
summarized in Figure 1 (32, 34, 35). Mechanisms associ-
ated with chemoprevention of aerodigestive tract cancers 
by berries may have therapeutic implications in aerodiges-
tive tract cancer research linked to petroleum exposure. 
For example, exposure to high levels of sulfur dioxide, 
nitrogen dioxide, ozone, carbon monoxide, ammonia and 
particulate matter has contributed to a marked increase 
in aerodigestive tract diseases especially carcinomas (41). 
Recent unpublished data support that cranberry proantho-
cyanidins can inhibit reflux-induced esophageal adenocar-
cinoma in part via modulation of bile salt and arachidonic 
acid cascade metabolites and altered microbiome profiles. 
These findings are in alignment with a limited but growing 
body of research reporting cranberry modulation of gut 
microbiota as well as cardiometabolic risk factors (42, 43). 
This body of resesarch is intriguing given that gut bacte-
ria play a large role in modifying not only nutrients but 
also toxicants, including those found in pollution. Some 
examples from that body of work: Anhe et al. (43) recently 
showed that a polyphenol-rich cranberry extract protects 
from diet-induced obesity, insulin resistance and intestinal 
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Figure 1: Cancer-inhibitory mechanisms associated with cranberries.
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inflammation in association with increased abundance of 
the mucin-degrading bacterium Akkermansia in the gut 
microbiota of mice. Additionally, cranberries and their 
bioactive constituents modulate bacterial adhesion, coag-
gregation and biofilm formation which may in turn reduce 
gastrointestinal and urinary tract infections and serve to 
reduce systemic inflammation (42). Cranberries have also 
shown efficacy against Helicobacter pylori (H.  pylori), a 
Gram-negative bacterium linked to peptic ulcer disease, 
gastric carcinoma and lymphoid tissue lymphoma (44, 45).
Bacterial virulence is sensitive to environmental cues 
including pH and iron, a limiting nutrient for bacteria 
during infection. Interestingly, many plant-derived flavo-
noids, including cranberry proanthocyanidins, contain 
“iron-binding motifs” which result in strong iron binding 
properties and cellular iron depletion (46, 47). Consid-
ering the high metabolic demands of tumors, natural 
products that target iron metabolism may prove promis-
ing for cancer inhibition or as a complement to standard 
chemotherapy regimens. The antioxidant properties of 
plant polyphenolics has been widely reported; yet, many 
of these constituents are redox reactive, forming iron com-
plexes that result in cytotoxic cancer cell death due to the 
generation of reactive oxygen species (48, 49). Cranberry 
proanthocyanidins have been reported to increase reactive 
oxygen species (ROS) levels in ovarian, neuroblastoma 
and esophageal adenocarcinoma cells leading to cancer 
cell death (35). Whether the chelation capacity of plant-
derived bioactives extends beyond iron to other heavy 
metals, such as mercury, arsenic and lead remains to be 
determined. Further study of such interactions between 
nutrients, toxicants and bacteria are warranted.
Investigations on the inhibitory effects of cranberries 
and cranberry-derived constituents on cancer are at an 
early stage, but are highly encouraging given the emerg-
ing positive preclinical effects and limited, but favorable 
clinical research associated with cranberry administra-
tion. Importantly, low concentrations which are achievable 
when administered in a drink formulation, consumed as 
food or as a supplement have been reported to elicit cancer 
inhibitory potential in preclinical models (32–35). Simi-
larly, consumption of cranberry-based products can inhibit 
Escherichia coli (E.  coli) induced urinary tract infections 
(32, 34, 50, 51).
In contrast, research of black raspberries as cancer 
inhibitors spans a longer time interval and has progressed 
to early phase clinical trials in a number of patient cohorts 
(36–39). Black raspberries can inhibit a broad range of 
cancers in preclinical models, including in vivo models 
of oral, esophageal, colon, breast and skin cancer (37). 
Promising preclinical results led to clinical evaluations 
in cancer patients or patients at increased risk for cancer 
development (36–39). Research investigating black rasp-
berries in the clinical setting report positive effects on 
preneoplastic lesions or cancers of the head and neck, 
esophagus and colon (38). Berry treatment can also mod-
ulate genes linked to RNA processing and growth factor 
recycling. For example, in the colon, black raspberries 
inhibited familial adenomatous polyposis (FAP)-associ-
ated polyp progression, demethylated tumor suppressor 
genes and improved plasma cytokine profiles (39). In 
Barrett’s esophagus patients, black raspberry consump-
tion increased tissue levels of glutathione S-transferase 
Pi (GST-pi) and decreased 8-isoprostane, a marker of lipid 
peroxidation and global oxidative stress (36). The precise 
dose, duration and optimum mode of black raspberry 
delivery for cancer inhibition remains to be fully eluci-
dated. Still, common themes across studies support that 
black raspberries can inhibit aberrant proliferation and 
inflammation, reduce oxidative stress and restore tumor 
suppressive activity.
Chemopreventive effects 
of  docosahexaenoic acid on 
 inflammation-associated 
carcinogenesis
In addition to plant-derived nutrients and bioactive com-
pounds, fish-derived long-chain omega-3 fatty acids have 
significant implications in the protection against inflam-
matory diseases, including those linked to pollution and 
cancer (52). Resolvins are thought to be the active metabo-
lites of omega-3 polyunsaturated fatty acids (PUFAs), and 
are responsible for facilitating the resolving phase of acute 
and chronic inflammation. Omega-3 PUFAs and resolvins 
can also modulate cancer progression (52). In addition 
to suppression of NFκB, activation of AMPK/SIRT1, and 
modulation of cyclooxygenase (COX) activity by omega-3 
PUFAs, up-regulation of anti-inflammatory lipid media-
tors such as protectins, maresins and resolvins, appear 
to be the main mechanisms of antineoplastic effects of 
omega-3 PUFAs (53).
The growth and metastatic potential of cancer cells 
are influenced by various neighboring cells that comprise 
the so-called ‘tumor microenvironment’. Therefore, the 
precise understanding of interactions between cancer 
cells and the surrounding environment is very essential 
for the discovery of novel anticancer targets and develop-
ment of efficient therapeutic and preventive strategies. 
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Chronic inflammation plays a multifaceted role in carcino-
genesis. Mounting evidence from preclinical and clinical 
studies suggests that persistent inflammation functions as 
a driving force in the journey to cancer (54). While inflam-
mation promotes development of cancer, components of 
the tumor microenvironment, such as tumor cells, stromal 
cells in surrounding tissue and infiltrated inflammatory/
immune cells (e.g. macrophages) generate an intratu-
moral inflammatory state by aberrant expression or 
activation of a distinct set of proinflammatory signaling 
molecules. Many of these inflammatory mediators, espe-
cially cytokines, chemokines and prostaglandins, turn 
on the angiogenic switches mainly controlled by vascular 
endothelial growth factor and induce tumor cell-stroma 
communication (54). This will end up with tumor angio-
genesis, metastasis and invasion.
Recently, much attention has been focused on diet-
derived natural products with cancer preventive and 
therapeutic potential. Over the past few decades, numer-
ous cancer chemopreventive and cytoprotective natural 
products have been identified that modulate key redox-
sensitive transcription factors, such as NF-κB, STAT3 and 
Nrf2  mediating pro- or anti-inflammatory signaling (55). 
For example, some spice ingredients, such as curcumin 
in turmeric [6], gingerol in ginger, capsaicin in hot chili 
pepper and diallyl trisulfide in garlic can have chemopre-
ventive effects on experimentally induced carcinogenesis 
(55). In addition to plant-derived nutrients and bioactive 
compounds, fish-derived long-chain omega-3 fatty acids 
have significant implications in the protection against 
inflammatory diseases and cancer (52). Also, docosahex-
aenoic acid (DHA), a prototypic omega-3 polyunsatu-
rated fatty acid (PUFA) abundant in fish oil, can inhibit 
colitis (56) and colon carcinogenesis in mice (57) as well 
as  Helicobacter-induced activation of STAT3 in gastric epi-
thelial cells (58).
The implication of inflammatory cell/tissue damage 
in the pathophysiology of human cancer and some meta-
bolic disorders has been under intense investigation 
both at the research level and in clinical practice. Reso-
lution of inflammation is an active coordinated process 
regulated by a distinct set of endogenous lipid media-
tors, such as resolvins, protectins aresins and lipoxins 
which are derived from omega-3 PUFAs. Inflammation is 
often expressed as “fire within”. By properly terminating 
the inflammation in an early stage, these endogeneous 
fire extinguishers prevent progression to chronic inflam-
mation. In searching for an efficacious way to prevent 
or treat inflammation-associated disorders, the under-
standing of pro-resolving signal transduction path-
ways and their regulators is also essential. Clearance 
of apoptotic neutrophils by macrophages, termed “effe-
rocytosis”, is an essential event in the resolution of 
inflammation. Recent studies have demonstrated that 
resolvin D1 derived from DHA stimulates the efferocyto-
sis by facilitating the degradation of p105, a precursor 
of p50 subunit of NF-κB and subsequently predominant 
formation of p50-p50 homodimer (59). This can hamper 
the formation and subsequent interaction of p50-p65, 
the functionally active heterodimer of NF-κB, with the 
κB binding site present in the promoter regions of many 
proinflammatory genes. Resolvin D1 also rescues mac-
rophages from oxidative stress-induced apoptosis during 
efferocytosis through protein kinase A (PKA)-mediated 
repression of NADPH oxidase (NOX) signaling and 
upregulation of anti-apoptotic protein expression (60).
Recent studies on the distinct set of metabolites 
derived from DHA have revealed the endogenous for-
mation of several novel lipid mediators which have 
proresolving as well as anti-inflammatory effects (59). 
Considering that acute inflammation, if not resolved 
properly and in a timely manner, becomes chronic and 
can cause various human diseases including cancer it 
is important to evaluate the chemopreventive and anti-
carcinogenic potential of those proresolving as well as 
anti-inflammatory substances that originate from DHA 
(59). With respect to negligible adverse effects of a correct 
supplementation of DHA, future development of thera-
peutically relevant, stable synthetic analogs of DHA and 
its metabolites capable of activating proresolving signal 
transduction while inhibiting unresolved inflammation 
merits further investigations (61).
Nutrition or diet-derived bioactive 
compounds can modulate environ-
mental insults
While a sedentary lifestyle and/or poor dietary habits can 
exacerbate the harmful effects of exposure to environmen-
tal pollutants, much emerging evidence suggests that pos-
itive lifestyle changes (e.g. healthful nutrition, exercise or 
increased physical activity) can modulate or reduce the 
toxicity of hazardous chemicals (62, 63). Diet can either 
increase or reduce the harmful effects associated with 
exposure to environmental pollutants. There is a signifi-
cant need to further explore the paradigm of nutrition in 
environmental toxicology and to improve our understand-
ing of the relationship between lifestyle modifications and 
toxicant-induced diseases.
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In vivo evidence of nutritional 
modulation of environmental 
insults
Modulation of PCB toxicity by dietary 
polyphenols
The paradigm of nutrition as a key factor modifying envi-
ronmental chemical (e.g. PCB) toxicity is of considerable 
interest to populations at risk, i.e. populations residing 
near hazardous waste sites or areas of contamination and 
populations with poor dietary habits. This is even more 
relevant when there also is a high incidence of infec-
tious diseases and malnutrition and it is well known that 
almost all nutrients in the diet play a crucial role in host 
resistance to infection (64). Exposure to environmental 
pollutants during vulnerable periods of life, i.e. during 
development and early childhood, can trigger more severe 
onset of non-communicable diseases later in life (25). 
Most importantly, the added stress of infectious diseases, 
poverty and malnutrition can compound the vulnerability 
to environmental chemical-mediated disease pathologies. 
For example, children around the world, and especially 
in many developing countries, are at higher risk for the 
development of diseases due to exposure to toxic sub-
stances in the environment (65) and especially persistent 
organic toxicants or POPs. There is sufficient evidence that 
POPs contribute to inflammation by activating oxidative 
stress-sensitive transcription factors such as NF-κB (66). 
For example, studies suggest that PCBs, and in particu-
lar coplanar PCBs, can increase cellular oxidative stress 
and induce inflammatory molecules, such as inflamma-
tory cytokines, chemokines and adhesion molecules, in 
the vascular endothelium, which are metabolic events 
that foster an inflammatory response and the pathology 
of atherosclerosis (63). Importantly, exposure to dioxin-
like PCBs can elicit epigenetic modifications related to 
activation of NF-κB (67). Epigenetic modifications of DNA 
and histones alter cellular phenotypes without changing 
genetic codes. A recent study demonstrated that endothe-
lial cell dysfunction induced by exposure to dioxin-like 
PCBs is mediated in part through histone modifications 
(68). Increased accumulation of the histone demethylase 
JMJD2B in the p65 promoter of NF-κB led to a depletion of 
H3K9me3 repression marks (67). This may account for the 
observed up-regulation of p65 and associated inflamma-
tory genes. These data suggest that dioxin-like PCBs may 
exert endothelial cell toxicity through changes in histone 
modifications (67, 68).
An accumulating body of evidence clearly shows that 
nutrition can modulate PCB toxicity (62, 63). For example, 
specific fatty acids present in many oils, such as linoleic 
acid (the parent omega-6 fatty acid), can amplify PCB 
toxicity in vascular endothelial cells, an event which can 
be down-regulated by vitamin E (63). Additionally, poly-
phenols and omega-3 PUFAs have been shown to decrease 
toxicant-induced maladies including liver diseases, tumor 
formation and growth and endothelial cell activation 
(63). Most importantly, plant-derived flavonoids such as 
epigallocatechin-3-gallate (EGCG), can decrease oxida-
tive stress and inflammation, and this observed protec-
tion may be in part controlled via epigenetic mechanisms 
(68). Understanding of the epigenetic control mechanisms 
of pollutant-induced diseases will allow for more focused 
therapeutic and preventative measures which can be 
implemented during developmental or early phases in life 
and thus may be highly applicable to the fields of public 
health and risk assessment.
Clinical evidence of nutritional 
modulation of environmental 
insults
Folic acid supplementation modulates 
arsenic methylation and blood arsenic levels
The World Health Organization (WHO) estimates that more 
than 140  million people in over 70 countries worldwide, 
including regions within the United States are exposed to 
arsenic-contaminated drinking water. Ingested inorganic 
arsenic undergoes methylation to mono- and di-methylated 
arsenical species, which facilitates renal arsenic elimina-
tion. This process relies on folate-dependent one-carbon 
metabolism for the synthesis of the universal methyl donor, 
s-adenosylmethionine (SAM). In folate deficient individu-
als, it was found that methylation of arsenic to the di-meth-
ylated species is augmented by folic acid supplementation 
(400 μg/day, i.e. the US Recommended Dietary Intake) 
thereby lowering blood arsenic (69, 70). In other studies, 
folate deficiency, assessed by plasma folate concentra-
tions, has been associated with a risk for arsenic-induced 
skin lesions and urothelial carcinoma (71, 72). In addition to 
folate, choline and betaine can also provide methyl groups 
for SAM biosynthesis, although these micronutrients have 
been less well studied with regard to arsenic methylation.
A more recent clinical trial in Bangladesh was con-
ducted to determine whether 400 or 800 μg folic acid 
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supplementation can increase arsenic methylation and 
thus lower blood arsenic in a random sample of arsenic-
exposed Bangladeshi adults (73). Most of the participants 
were not folate deficient. The major findings of this study 
included that treatment with 800 μg folic acid lowered 
blood arsenic to a greater extent than placebo (73). Folic 
acid supplementation rapidly and significantly increased 
arsenic methylation, which was sustained in those partici-
pants who continued their folic acid regimen, but was not 
sustained in those who switched to placebo for 12 weeks, 
illustrating the importance of maintaining folate nutri-
tional status. Future studies will be needed to determine if 
folate supplementation can prevent or potentially reverse 
clinical signs of arsenic toxicity.
While fortification of food with folic acid is mandated 
by law in 86 countries and can virtually eradicate folate 
deficiency, the 10 countries with the most significant 
problems of arsenic-contaminated drinking water do not 
have mandatory folate fortification programs (74). Future 
studies should evaluate folate nutritional status and 
arsenic methylation capacity in other countries having 
significant problems of arsenic-contaminated drinking 
water.
Epidemiological studies of healthful nutrition 
and protection against  environmental insults
Data from the National Health and Nutrition Examina-
tion Survey (NHANES) 2003–2004 predicted a reduced 
probability of dioxin-like PCB-associated risk for type 2 
diabetes in people with higher dietary intake of fruit and 
vegetables, as reflected by serum carotenoid concentra-
tions (75). In another study among older Chinese adults, 
it was found that long-term exposure to ambient fine 
particle pollution contributed significantly to hyperten-
sion in this population group (76). It was also observed 
that higher consumption of fruit might mitigate, whereas 
overweight and obesity could enhance this pollution-
induced risk of hypertension (76). Most of all, interac-
tions between nutrition and air pollution are particularly 
critical during developmental phases, and thus could 
possibly alter the odds of congenital heart defects in off-
spring (77).
Many POPs are lipophilic and can accumulate 
within adipose tissues of exposed individuals. Thus, 
nutritional intervention to promote excretion and 
reduction of body burden can also be important to 
lower disease risks. This has been demonstrated in 
a case study of accidental exposure to Aroclor 1254, 
where treatment with the dietary fat substitute olestra 
for over 2 years normalized initial symptoms of type 2 
diabetes, mixed hyperlipidemia and chloracne (78). A 
follow-up study with residents residing near a highly 
contaminated site with POPs (e.g. PCBs) demonstrated 
that foods enriched with olestra can safely reduce body 
burdens of PCBs (79). It has been suggested that olestra, 
and possibly plant-derived polyphenols, can enhance 
the excretion rate in individuals exposed to high con-
centrations of PCBs through interference with the enter-
ohepatic circulation of these pollutants (79, 80).
Conclusion
The paradigm of nutrition as a key factor modifying envi-
ronmental chemical (e.g. PCB) toxicity is of considerable 
interest to populations at risk, such as populations resid-
ing near hazardous waste sites or areas of contamination 
and populations with poor dietary habits. This is even 
more relevant when there also is a high incidence of infec-
tious diseases and malnutrition, as it is well known that 
almost all nutrients in the diet play a crucial role in host 
resistance to infection (64). This may be especially relevant 
in Southeast Asian regions of the world where infectious 
diseases, poverty and malnutrition are prevalent. Further-
more, the role of nutrition in cumulative risk assessment 
is being further substantiated not only as an important 
modulator of inflammatory and antioxidant pathways, 
especially associated with environmental insults, but also 
due to its link to the pathologies of non-communicable or 
chronic diseases (81). Diets rich in antioxidants and anti-
inflammatory nutrients can improve health and decrease 
vulnerability to additional chemical stressors (Figure 1). 
Thus, healthful nutrition intervention may be most effec-
tive if it is considered as early in life as possible. This is 
especially prudent in children who are malnourished and 
also suffer from infections (64). In fact, a healthy diet 
could markedly buffer the body against chemical, biologi-
cal and physical stressors that humans are exposed to on a 
daily basis. In summary, positive lifestyle changes, includ-
ing healthful dietary behaviors and food choices, can 
potentially reduce health risks associated with exposure 
to hazardous substances or reduce the overall vulnerabil-
ity to environmental insults. This suggests that nutritional 
interventions may provide the most sensible prevention 
strategy against diseases associated with many environ-
mental toxic insults. Looking forward, it will be important 
to conduct more human clinical studies to document and 
quantify the potential benefits of nutritional interventions 
in reducing incidence and progression of disease.
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